Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations

Medicine, Cardiology, Health Technology Assessment +13

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial

David E. Kandzari, Laura Mauri, Jacques Koolen et al. · The Lancet · 2017 · 271 citations

Medicine, Cardiology, Pharmacotherapy +17

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial

Juan F. Iglesias, Olivier Müller, Dik Heg et al. · The Lancet · 2019 · 188 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial

Thomas Pilgrim, Raffaele Piccolo, Dik Heg et al. · The Lancet · 2018 · 130 citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +15

Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents

David E. Kandzari, Jacques Koolen, Gheorghe Doros et al. · Journal of the American College of Cardiology · 2018 · 89 citations · Full text

Medicine, Cardiology, Biomaterials +14